HELIX BIOPHARMA CORP (HBP.CA) Stock Balance Sheet
TSX:HBP - Toronto Stock Exchange - CA4229102088 - Common Stock - Currency: CAD
| MRQ (2025-4-30) | 2024 (2024-7-31) | 2023 (2023-7-31) | 2022 (2022-7-31) | 2021 (2021-7-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 715.00K | 1.08M | 808.00K | 3.25M | 3.56M | |||
| Receivables | 32.00K | 54.00K | 62.00K | 279.00K | 353.00K | |||
| Other Current Assets | 255.00K | 321.00K | 126.00K | 164.00K | 100.00K | |||
| Total Current Assets | 1.00M | 1.46M | 996.00K | 3.69M | 4.02M | |||
| Non-Current Assets | ||||||||
| PPE Net | 7.00K | 33.00K | 33.00K | 36.00K | 47.00K | |||
| Other Non-Current Assets | N/A | N/A | N/A | -1.00K | N/A | |||
| Total Non-Current Assets | 7.00K | 33.00K | 33.00K | 35.00K | 47.00K | |||
| TOTAL ASSETS | 1.01M | 1.49M | 1.03M | 3.73M | 4.07M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 2.47M | 2.03M | |||
| Accrued Expenses | 617.00K | 724.00K | 383.00K | 345.00K | 380.00K | |||
| Accounts Payable | 1.78M | 855.00K | 493.00K | 599.00K | 1.47M | |||
| Other Current Liabilities | N/A | 0.00 | 998.00K | -1.00K | 0.00 | |||
| Total Current Liabilities | 2.40M | 1.58M | 1.87M | 3.41M | 3.87M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 1.58M | |||
| Other Non-Current Liabilities | N/A | N/A | -1.00K | N/A | N/A | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | -1.00K | 0.00 | 1.58M | |||
| TOTAL LIABILITIES | 2.40M | 1.58M | 1.87M | 3.41M | 5.46M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -211.07M | -206.02M | -197.05M | -184.78M | -168.92M | |||
| Additional Paid In Capital | 48.30M | 47.36M | 44.14M | 37.59M | 27.87M | |||
| Minority Interest | N/A | N/A | N/A | N/A | 0.00 | |||
| Common Shares | 161.39M | 158.57M | 152.07M | 147.51M | 139.66M | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 53.15M | 49.02M | 40.00M | 34.36M | 28.23M | |||
| Tangible Book Value per Share | -0.03 | -0.00 | -0.02 | 0.01 | -0.05 | |||
| Total Shareholders' Equity | -1.39M | -90.00K | -844.00K | 319.00K | -1.39M | |||
| TOTAL LIABILITIES AND EQUITY | 1.01M | 1.49M | 1.03M | 3.73M | 4.07M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | -1.14 | |||
| Current Ratio | 0.42 | 0.92 | 0.53 | 1.08 | 1.04 | |||
| Return On Assets (ROA) | -944.80% | -622.16% | -611.27% | -175.95% | -197.74% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | -2057.37% | N/A | |||
All data in CAD , ROIC based on taxRate of 0.28